SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 1, 2006
Natus Medical Incorporated
-------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
------------------------------ -------------------- --------------------------
Delaware 000-33001 77-0154833
------------------------------ -------------------- --------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
------------------------------ -------------------- --------------------------
1501 Industrial Road, San Carlos, California 94070
------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (650) 802-0400
-------------------------
Not applicable
------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On November 1, 2006, Natus Medical Incorporated (the "Company") is issuing a
press release and holding a conference call regarding its financial results for
the third quarter of fiscal 2006 ended September 30, 2006 and other financial
information. A copy of the press release is furnished as Exhibit 99.1 to this
Form 8-K.
The information in this Form 8-K and the exhibit attached hereto shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934
(the "Exchange Act") or otherwise subject to the liabilities of that Section,
nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act, except as shall be expressly set
forth by specific reference in such a filing.
ITEM 9.01. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
Exhibit No. Description
------------ -----------
99.1 Press release of Natus Medical Incorporated dated November 1,
2006 describing the Company's results for its third fiscal
quarter ended September 30, 2006 and other financial information.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NATUS MEDICAL INCORPORATED
Date: November 1, 2006 By: /s/ Steven J. Murphy
----------------------------------
Steven J. Murphy
Vice President Finance
and Chief Financial Officer
Index to Exhibits
Exhibit No. Description
------------ -----------
99.1 Press release of Natus Medical Incorporated dated November 1,
2006 describing the Company's results for its third fiscal
quarter ended September 30, 2006 and other financial information.